Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors

A series of succinyl hydroxamate MMP inhibitors were prepared incorporating an aryl amino ketone moiety in place of the more typical C-terminal amino acid amides. Compounds of the C-terminal ketone series displayed potent inhibition of MMPs. Several compounds of the series were shown to be orally bi...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry letters Vol. 8; no. 22; pp. 3251 - 3256
Main Authors: Sheppard, George S., Florjancic, Alan S., Giesler, Jamie R., Xu, Lianhong, Guo, Yan, Davidsen, Steven K., Marcotte, Patrick A., Elmore, Ildiko, Albert, Daniel H., Magoc, Terrance J., Bouska, Jennifer J., Goodfellow, Carole L., Morgan, Douglas W., Summers, James B.
Format: Journal Article
Language:English
Published: Oxford Elsevier Ltd 17-11-1998
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A series of succinyl hydroxamate MMP inhibitors were prepared incorporating an aryl amino ketone moiety in place of the more typical C-terminal amino acid amides. Compounds of the C-terminal ketone series displayed potent inhibition of MMPs. Several compounds of the series were shown to be orally bioavailable. A series of succinyl hydroxamate MMP inhibitors were prepared incorporating an aryl amino ketone moiety in place of the more typical C-terminal amino acid amides. Compounds of the C-terminal ketone series displayed potent inhibition of MMPs. Several compounds of the series were shown to be orally bioavailable.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0960-894X
1464-3405
DOI:10.1016/S0960-894X(98)00597-6